Filter
315
Filtered Results: 315
Text search:
dexaméthasone
Featured
Recommendations
52
New Publications
68
Language
Document type
No document type
137
Guidelines
103
Studies & Reports
28
Manuals
22
Fact sheets
8
Training Material
7
Strategic & Response Plan
5
Resource Platforms
2
Infographics
2
Situation Updates
1
Countries / Regions
India
27
Brazil
12
Ethiopia
12
Kenya
10
Rwanda
10
Latin America and the Carribbean
9
Paraguay
9
Nepal
8
Mozambique
7
Germany
7
Senegal
6
Bangladesh
6
South Africa
6
Indonesia
6
Global
5
Nigeria
4
Guinea-Bissau
4
Congo, Democratic Republic of
4
Bolivia
4
Argentina
4
Uganda
4
Angola
4
Cameroon
3
Syria
3
Malawi
3
Haiti
3
Tanzania
3
West and Central Africa
3
Russia
3
Zambia
3
Liberia
3
Myanmar / Burma
3
El Salvador
2
Ghana
2
Chile
2
Burkina Faso
2
Zimbabwe
2
Africa
2
Middle East and North Africa
2
East and Southern Africa
2
Namibia
2
South Sudan
2
Colombia
1
Ukraine
1
Benin
1
Sierra Leone
1
Gambia
1
Fiji
1
Malaysia
1
Philippines
1
Guinea
1
Cambodia
1
Venezuela
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Côte d’Ivoire / Ivory Coast
1
Yemen
1
Mali
1
Libya
1
Bhutan
1
Botswana
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
192
Clinical Guidelines
45
Women & Child Health
16
Key Resources
5
Public Health
4
Pharmacy & Technologies
1
Toolboxes
COVID-19
79
Pharmacy
32
TB
20
NTDs
9
Caregiver
8
Mental Health
7
Conflict
7
AMR
4
Rapid Response
3
HIV
3
Global Health Education
3
Planetary Health
2
Disability
1
Ebola & Marburg
1
Health Financing Toolbox
1
NCDs
1
The unmet need for palliative care in Cox’s Bazar
Since the description of the first case of COVID-19 in Wuhan, Hubei province in China, in December 2019, much knowledge has been accumulated about the dynamics of evolution of the SARS-CoV-2 virus, contagion, disease progression, prevention and treatment.
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier methods under contraceptives has been deleted and moved to medical supplies and equipment list. A section...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
Updated July 3, 2020
Prepared by the Independent Panel for Pandemic Preparedness and Response for the WHO Executive Board, January 2021
“The world was not as prepared as it should have been, and it must do better,” concludes a WHO panel reviewing the pandemic response "
